牛叉诊股

[{"date":"2026.03.17","stock":"-1.88","trade":"-2.13","ind":"-1.87"},{"date":"2026.03.16","stock":"-0.23","trade":"0.31","ind":"0.19"},{"date":"2026.03.13","stock":"0.47","trade":"-0.19","ind":"-0.65"},{"date":"2026.03.12","stock":"-2.07","trade":"-1.28","ind":"-0.63"},{"date":"2026.03.11","stock":"-1.59","trade":"-0.50","ind":"0.78"},{"date":"2026.03.10","stock":"0.92","trade":"2.52","ind":"2.04"},{"date":"2026.03.09","stock":"-2.24","trade":"-0.15","ind":"-0.74"},{"date":"2026.03.06","stock":"3.00","trade":"3.07","ind":"0.59"},{"date":"2026.03.05","stock":"1.40","trade":"1.64","ind":"1.23"},{"date":"2026.03.04","stock":"1.90","trade":"-0.56","ind":"-0.75"},{"date":"2026.03.03","stock":"-3.23","trade":"-4.75","ind":"-3.07"},{"date":"2026.03.02","stock":"-3.98","trade":"-3.43","ind":"-0.20"},{"date":"2026.02.27","stock":"0.44","trade":"0.72","ind":"-0.06"},{"date":"2026.02.26","stock":"-0.66","trade":"-0.69","ind":"0.19"},{"date":"2026.02.25","stock":"1.34","trade":"1.27","ind":"1.29"},{"date":"2026.02.24","stock":"2.29","trade":"-0.11","ind":"1.36"},{"date":"2026.02.13","stock":"0.00","trade":"-1.09","ind":"-1.28"},{"date":"2026.02.12","stock":"-1.58","trade":"-0.49","ind":"0.86"},{"date":"2026.02.11","stock":"-0.45","trade":"-0.82","ind":"-0.35"},{"date":"2026.02.10","stock":"0.45","trade":"0.35","ind":"0.02"},{"date":"2026.02.09","stock":"0.00","trade":"1.32","ind":"2.17"}]

澳洋健康,深证成指,医疗服务指数

压力支撑

该股压力位为4.24元，支撑位为4.15元。

[{"text":"\u538b\u529b\u4f4d","value":"4.24","date":1773676800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.15","date":1773676800,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。已发现中线买入信号。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.9资金面打败了40%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：03月17日 20:30

机构今日流向(万元)	-388.48	机构5日流向(万元)	-7492.89
机构10日流向(万元)	-8521.90	机构20日流向(万元)	-21155.57

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加915.57万股，其中基金净减仓5家，主力净减仓4家，暂未发现中长期投资价值。

截止2025-06-30，共13家主力机构（基金7家，QFII5家，一般法人1家），持仓量总计25078.49万股，占流通A股32.77%
其中，基金持仓与2024-12-31相比：
增仓：1家，增持 0.78万股
减仓：6家，减持 5.29万股
新出现在主力名单中：3家，持有823.27万股
从主力名单中消失：7家，原持有159.44万股

消息面诊股

诊断结果：5.5消息面打败了29%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	取消监事会	2025-12-18
一般消息	重大事项	公司股东股份解押	2025-12-04
一般消息	股东大会	临时股东大会	2025-12-03
一般消息	重大事项	公司股东股份解押	2025-11-25
一般消息	资产重组	公司股权转让	2025-11-07
一般消息	重大事项	公司股东股份解押	2025-10-23
一般消息	分红转增	不分配不转增	2025-08-27
一般消息	资产重组	公司股权转让	2025-07-30
一般消息	重大事项	关联交易	2025-05-08
一般消息	分红转增	不分配不转增	2025-04-15
一般消息	重大事项	关联交易	2025-04-15

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	0条	0条	0条

行业面诊股

诊断结果：7.7行业面打败了92%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.03.17","price":"-1.87","value":"-2.13"},{"date":"2026.03.16","price":"0.19","value":"0.31"},{"date":"2026.03.13","price":"-0.65","value":"-0.19"},{"date":"2026.03.12","price":"-0.63","value":"-1.28"},{"date":"2026.03.11","price":"0.78","value":"-0.50"},{"date":"2026.03.10","price":"2.04","value":"2.52"},{"date":"2026.03.09","price":"-0.74","value":"-0.15"},{"date":"2026.03.06","price":"0.59","value":"3.07"},{"date":"2026.03.05","price":"1.23","value":"1.64"},{"date":"2026.03.04","price":"-0.75","value":"-0.56"},{"date":"2026.03.03","price":"-3.07","value":"-4.75"},{"date":"2026.03.02","price":"-0.20","value":"-3.43"},{"date":"2026.02.27","price":"-0.06","value":"0.72"},{"date":"2026.02.26","price":"0.19","value":"-0.69"},{"date":"2026.02.25","price":"1.29","value":"1.27"},{"date":"2026.02.24","price":"1.36","value":"-0.11"},{"date":"2026.02.13","price":"-1.28","value":"-1.09"},{"date":"2026.02.12","price":"0.86","value":"-0.49"},{"date":"2026.02.11","price":"-0.35","value":"-0.82"},{"date":"2026.02.10","price":"0.02","value":"0.35"},{"date":"2026.02.09","price":"2.17","value":"1.32"}]

深证成指,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	*ST生物	15.61%	2.61%	5.9分
2	盈康生命	12.86%	8.07%	6.0分
3	百奥赛图	12.46%	-2.78%	7.1分
4	ST中珠	11.31%	-3.79%	5.2分
5	诚达药业	7.94%	-7.76%	4.8分
6	海特生物	4.04%	-6.23%	5.2分
7	百诚医药	3.68%	-1.63%	5.1分
8	国际医学	2.23%	0.40%	4.9分
9	新里程	2.07%	-0.81%	5.8分
10	创新医疗	1.71%	0.24%	6.0分
11	和元生物	0.41%	-6.96%	5.0分
12	普瑞眼科	-0.14%	1.13%	6.7分
13	华康洁净	-0.69%	-7.17%	5.2分
14	百花医药	-1.28%	-0.75%	5.6分
15	三博脑科	-1.65%	-2.47%	5.3分
16	光正眼科	-3.76%	-4.36%	5.7分
17	凯莱英	-4.25%	-2.57%	6.0分
18	爱尔眼科	-4.38%	-0.68%	4.5分
19	阳光诺和	-4.52%	-0.50%	5.6分
20	何氏眼科	-5.36%	-4.22%	6.2分
21	皓元医药	-5.63%	8.49%	5.6分
22	澳洋健康	-5.86%	-5.22%	5.3分
23	博济医药	-6.30%	-3.20%	5.1分
24	药明康德	-6.32%	-1.80%	6.1分
25	金凯生科	-6.36%	-0.88%	6.4分
26	皓宸医疗	-6.56%	-3.72%	5.0分
27	万邦医药	-6.70%	-4.98%	4.1分
28	九洲药业	-6.85%	-0.59%	5.0分
29	华厦眼科	-7.17%	-1.12%	5.6分
30	毕得医药	-7.48%	-4.62%	5.4分
31	南模生物	-7.93%	-5.66%	5.2分
32	康龙化成	-8.35%	0.51%	5.8分
33	睿智医药	-8.44%	-3.72%	5.9分
34	兰卫医学	-8.87%	-3.35%	6.0分
35	通策医疗	-9.09%	-5.37%	5.0分
36	诺禾致源	-9.89%	-2.54%	4.6分
37	药石科技	-10.38%	-1.51%	4.6分
38	-	-10.39%	-9.69%	分
39	益诺思	-10.73%	-0.22%	5.6分
40	华大基因	-10.85%	-2.28%	4.3分
41	博腾股份	-11.22%	-1.40%	5.1分
42	贝瑞基因	-11.31%	-6.55%	4.3分
43	美迪西	-11.43%	-16.09%	4.8分
44	金域医学	-13.76%	-3.48%	4.5分
45	药康生物	-14.19%	-3.59%	5.3分
46	美年健康	-14.89%	-6.54%	5.0分
47	奥浦迈	-15.78%	-5.30%	5.4分
48	成都先导	-16.31%	-9.03%	5.1分
49	泓博医药	-17.79%	-6.03%	5.4分
50	泰格医药	-19.26%	-8.39%	5.9分
51	昭衍新药	-21.39%	-14.59%	4.5分
52	迪安诊断	-21.40%	-6.80%	4.6分
53	诺思格	-21.64%	-8.89%	5.0分
54	普蕊斯	-23.16%	-15.08%	5.1分

<上一页 1 2 3 4 5...9 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
国都证券	2012-09-11	中性	增持
民族证券	2012-09-11	增持	-
长城证券	2012-09-10	中性	中性
民生证券	2012-09-10	中性	中性
东北证券	2012-09-10	中性	中性

基本面诊股

诊断结果：5.6基本面打败了40%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（35分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 1/102 ， 50/102。

[{"date":"2025-09-30","value":"25.95","vol":"3.33"},{"date":"2025-06-30","value":"21.00","vol":"2.29"},{"date":"2025-03-31","value":"12.87","vol":"0.92"},{"date":"2024-12-31","value":"35.52","vol":"-0.06"},{"date":"2024-09-30","value":"34.16","vol":"3.18"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	25.95	21.00	12.87	35.52	34.16
行业(%)	3.33	2.29	0.92	-0.06	3.18

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"14.27","vol":"36.63"},{"date":"2025-06-30","value":"14.85","vol":"36.78"},{"date":"2025-03-31","value":"15.09","vol":"34.67"},{"date":"2024-12-31","value":"13.39","vol":"35.58"},{"date":"2024-09-30","value":"13.72","vol":"36.89"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	14.27	14.85	15.09	13.39	13.72
行业(%)	36.63	36.78	34.67	35.58	36.89

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 41/102 ， 32/102。

[{"date":"2025-09-30","value":"-9.39","vol":"3.55"},{"date":"2025-06-30","value":"-12.49","vol":"3.34"},{"date":"2025-03-31","value":"-22.27","vol":"-0.08"},{"date":"2024-12-31","value":"-7.54","vol":"-0.03"},{"date":"2024-09-30","value":"-7.54","vol":"0.85"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-9.39	-12.49	-22.27	-7.54	-7.54
行业(%)	3.55	3.34	-0.08	-0.03	0.85

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"3.71","vol":"19.50"},{"date":"2025-06-30","value":"-15.46","vol":"-66.44"},{"date":"2025-03-31","value":"-39.82","vol":"-25.93"},{"date":"2024-12-31","value":"-18.36","vol":"-92.66"},{"date":"2024-09-30","value":"-2.39","vol":"-158.04"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	3.71	-15.46	-39.82	-18.36	-2.39
行业(%)	19.50	-66.44	-25.93	-92.66	-158.04

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 1/102 ， 17/102。

[{"date":"2025-09-30","value":"0.68","vol":"0.31"},{"date":"2025-06-30","value":"0.45","vol":"0.20"},{"date":"2025-03-31","value":"0.22","vol":"0.10"},{"date":"2024-12-31","value":"0.94","vol":"0.41"},{"date":"2024-09-30","value":"0.72","vol":"0.31"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.68	0.45	0.22	0.94	0.72
行业(次)	0.31	0.20	0.10	0.41	0.31

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"8.24","vol":"11.19"},{"date":"2025-06-30","value":"5.42","vol":"7.29"},{"date":"2025-03-31","value":"2.43","vol":"3.76"},{"date":"2024-12-31","value":"10.46","vol":"16.08"},{"date":"2024-09-30","value":"7.14","vol":"13.98"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	8.24	5.42	2.43	10.46	7.14
行业(次)	11.19	7.29	3.76	16.08	13.98

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"5.78","vol":"16.25"},{"date":"2025-06-30","value":"27.70","vol":"15.87"},{"date":"2025-03-31","value":"-39.80","vol":"-1.69"},{"date":"2024-12-31","value":"45.18","vol":"22.45"},{"date":"2024-09-30","value":"5.15","vol":"12.75"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	5.78	27.70	-39.80	45.18	5.15
行业	16.25	15.87	-1.69	22.45	12.75

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.57","vol":"0.93"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.41","vol":"1.29"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.57	-	0.41	-
行业	0.01	0.93	0.00	1.29	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/102 ， 13/102。

[{"date":"2025-09-30","value":"0.65","vol":"3.76"},{"date":"2025-06-30","value":"0.64","vol":"3.66"},{"date":"2025-03-31","value":"0.66","vol":"3.84"},{"date":"2024-12-31","value":"0.65","vol":"3.66"},{"date":"2024-09-30","value":"0.62","vol":"4.04"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	0.65	0.64	0.66	0.65	0.62
行业	3.76	3.66	3.84	3.66	4.04

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.55","vol":"3.03"},{"date":"2025-06-30","value":"0.54","vol":"2.95"},{"date":"2025-03-31","value":"0.54","vol":"3.12"},{"date":"2024-12-31","value":"0.55","vol":"2.98"},{"date":"2024-09-30","value":"0.48","vol":"3.32"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	0.55	0.54	0.54	0.55	0.48
行业	3.03	2.95	3.12	2.98	3.32

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 50/102 ， 1/102。

[{"date":"2025-09-30","value":"91.97","vol":"32.25"},{"date":"2025-06-30","value":"92.58","vol":"33.24"},{"date":"2025-03-31","value":"93.46","vol":"32.24"},{"date":"2024-12-31","value":"94.38","vol":"32.93"},{"date":"2024-09-30","value":"94.13","vol":"30.45"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	91.97	92.58	93.46	94.38	94.13
行业(%)	32.25	33.24	32.24	32.93	30.45

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"10.16","vol":"0.92"},{"date":"2025-06-30","value":"10.97","vol":"0.96"},{"date":"2025-03-31","value":"12.52","vol":"0.98"},{"date":"2024-12-31","value":"14.39","vol":"1.03"},{"date":"2024-09-30","value":"13.72","vol":"0.83"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	10.16	10.97	12.52	14.39	13.72
行业(%)	0.92	0.96	0.98	1.03	0.83

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"-10.39","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.15","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.50","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.41","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[澳洋健康]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]